Drug Trial Radar · NCT06328712
Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A(CMT1A) (Phase 1b: Open-label, Dose-escalation, Single-center; Phase 2a: Randomized, Double-blind, Placebo-controlled, Multicenter)
Last checked: Nov 20, 2026Latest source record: May 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
27
Planned (sponsor's estimate)
Start
May 30, 2024
Primary completion
Dec 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- ENCellIndustry
- Sponsor type
- Industry
- First posted
- Mar 25, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 1b/2a Clinical Trial to Evaluate the Safety and Efficacy of EN001 in Patients with Charcot-Marie-Tooth Disease type 1A(CMT1A) (Phase 1b: Open-label, Dose-escalation, Single-center; Phase 2a: Randomized, Double-blind, Placebo-controlled, Multicenter)
Conditions
- Charcot-Marie-Tooth Disease Type 1A
Interventions
EN001Drug
* Cohort 1: EN001 Low dose administered intravenously (IV) 2 times at 4 week intervals. * Cohort 2: EN001 High dose administered intravenously (IV) 2 times at 4 week intervals.
EN001 PlaceboDrug
EN001 Placebo administered intravenously (IV) 2 times at 4 week intervals.
Primary outcomes
What the sponsor says the trial is designed to measure.
- [Phase 1b] Dose limiting toxicity (DLT) and adverse drug reactions related to discontinuation of investigational product administrationTime frame: Up to 8 weeks
- [Phase 2a] Change from baseline in the CMT Neuropathy Score (CMTNSv2) at Week 24.Time frame: at Week 24
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Dongguk University Gyeongju Hospital
Gyeongju, South Korea · Recruiting
Kyung Hee University Hospital at Gangdong
Seoul, South Korea · Recruiting
Samsung Medical Center
Seoul, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.